Cargando…
Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings
BACKGROUND: Type 2 diabetes is associated with an increased cardiovascular risk. Use of aspirin has been shown to be of benefit for secondary prevention of cardiovascular disease in patients with type 2 diabetes; benefits in primary prevention have not been clearly proven. AIMS: This study aims to (...
Autores principales: | Tan, Shi Ying, Cronin, Heather, Byrne, Stephen, O’Donovan, Adrian, Tuthill, Antoinette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135889/ https://www.ncbi.nlm.nih.gov/pubmed/34156663 http://dx.doi.org/10.1007/s11845-021-02649-5 |
Ejemplares similares
-
Budget Impact of Appropriate Low-Dose Aspirin Use for Primary and Secondary Cardiovascular Event Prevention in the Managed Care Setting
por: Carlton, Rashad, et al.
Publicado: (2018) -
Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
por: Sicras-Mainar, Antoni, et al.
Publicado: (2007) -
Aspirin for primary prevention of cardiovascular disease in diabetes
por: Xing, Ying, et al.
Publicado: (2019) -
Missed opportunities in aspirin prescribing for preeclampsia prevention
por: Singh, Noreen, et al.
Publicado: (2023) -
Aspirin prescribing pattern and guidelines-adherence evaluation for primary prevention of cardiovascular diseases at a teaching hospital
por: Almalki, Salman, et al.
Publicado: (2021)